Dr. Jarrod D. Friedman, MD

Dr. Friedman practices at Laboratory Corporation of America Holdings in Durham, North Carolina.

Dr. Friedman's NPI, 1730192915, was assigned on August 15, 2006. Dr. Friedman graduated from Ross University School of Medicine in 1998. Dr. Friedman holds Florida license ME107418.

Dr. Friedman's primary practice is Laboratory Corporation of America Holdings, at 1904 T W Alexander Dr, Durham, NC 27703 in Durham County. The practice phone is (800) 833-3984.

Dr. Friedman's primary practice is Laboratory Corporation of America Holdings in Durham, North Carolina. Dr. Friedman is also affiliated with Boca Raton Regional Hospital. The medical group on file is Brain and Spine Center of South Florida Neurosurgery & Pain Management - Delray Beach. Dmand AI also links Dr. Friedman to 3 more hospitals, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Friedman practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional pain medicine is Dr. Friedman's primary specialty in the NPI Registry, under taxonomy code 208VP0014X. Dr. Friedman is board certified in pain medicine by the American Board of Physical Medicine and Rehabilitation. Dmand AI has Dr. Friedman's licenses on file in 9 states: Florida, Maryland, Illinois, Virginia, Arizona, District of Columbia, Indiana, Michigan and Pennsylvania.

Dmand AI lists arthritis, back pain injection, fibromyalgia and chronic pain, joint pain, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems and rotator cuff injury among the conditions Dr. Friedman treats.

CMS data shows 6,123 Medicare services from Dr. Friedman across 24 procedure codes in 2024, for 317 Medicare patients. Medicare paid $268,079 for them. Every service was in an office.

CMS counts 317 Medicare patients who saw Dr. Friedman in 2024. The largest group is 75 to 84, with 149 patients. 75% of them have arthritis, and 75% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Friedman's median patient age at 74, with 57% women.

In 2024, Dr. Friedman wrote 1,335 Medicare Part D claims for 179 patients. 95% of them were for generic drugs. CMS names the drug for 1,226 of them, across 20 drugs with 11 or more claims each, at $38,317 in total drug cost. In 2023, CMS named 1,698 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Friedman for performance year 2024, reported individually. Dr. Friedman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Friedman as offering telehealth.

Laminectomy or laminotomy (partial removal of spine bones): 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 238 general payments to Dr. Friedman from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Abbott Laboratories paid the most, $2,427.

Dr. Friedman graduated from Ross University School of Medicine in 1998. Dr. Friedman is a member of AAPMR.

Dr. Friedman is in network with 9 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.